Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Stemcells Inc (NASDAQ: STEM)

$1.28 USD $0.05 (4.07%)
Last Price $1.28
Net Change $0.05 (4.07%)
Bid $
Ask Price $
Open Price $1.26
Previous Close Price $1.23
High Price $1.48
Low Price $1.15
Number of Trades 3,444
Volume 2,851,200
Fifty Two Week High $6.72 (2015-12-01)
Fifty Two Week Low $0.33 (2016-06-24)
Average Daily Volume 1,220,609
Share Outstanding 16,260 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-2.25
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0.013%
Annual Revenue $0B
No. Shares Outstanding 16,260
Inst. Shareholder % 8.76%
Annual Net Income $-0.02B
TTM Net Profit Margin $-18409.09
1-Year Return -80.61%
3-Year Return -202.42%
5-Year Return -94.14%
5-Year Revenue Growth -91.55%
5-Year Earnings Growth -81.91%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-12
Beta 0.07
Stemcells, Inc. is engaged in research aimed at the development of therapies that would use stem and progenitor cells derived from fetal or adult sources to treat, and possibly cure, human diseases and injuries such as Parkinson's disease, hepatitis, diabetes, and spinal cord injuries.